Conventional radiography and correlated factors of enthesopathies of the Achilles tendon and plantar fascia in patients with axial spondyloarthritis

Ebru Yılmaz; Özge Pasin; Loiane Cristina de Souza; Guilherme Torres Vilarino; Alexandro Andrade; Camila Gusmão Vicente de Carvalho; Barbara Bayeh; Fernando Henrique Carlos de Souza; Renata Miossi; Pleiades Tiharu Inaoka; Takashi Matsushita; Naoki Mugii; Samuel Katsuyuki Shinjo

doi:10.4081/reumatismo.2024.1709

Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

Search Results

##search.searchResults.foundPlural##

Psoriatic arthritis: treatment strategies using biologic agents

S. D'Angelo, C. Palazzi, I. Olivieri

113-121

05-06-2012

https://doi.org/10.4081/reumatismo.2012.113

1276

PDF: 1181
Psoriatic arthritis. When the heterogeneity requires normality

L. Punzi, R. Ramonda

59-65

05-06-2012

https://doi.org/10.4081/reumatismo.2012.59

865

PDF: 710
BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

D.D. Gladman

85-87

https://doi.org/10.4081/reumatismo.2007.1s.85

635

PDF: 568
Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

M. Manara, D. Bruno, M. Ferrito, S. Perniola, R.F. Caporali, E. Gremese

11-09-2024

https://doi.org/10.4081/reumatismo.2024.1781

1662

PDF: 865
Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

G. Lapadula

22-29

https://doi.org/10.4081/reumatismo.2005.4s.22

789

PDF: 1084
Treatment of Wegener’s granulomatosis

V. Riccieri, G. Valesini

69-76

https://doi.org/10.4081/reumatismo.2004.69

1338

PDF: 5222
The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet

P. Sfriso, F. Salaffi, S. Bombardieri, B. Canesi, C.M. Montecucco, S. Todesco

77-84

https://doi.org/10.4081/reumatismo.2008.77

1783

PDF: 834
Approved indications and other possible utilizations of anti-TNFa biologic drugs

W. Grassi, C. Montecucco

30-33

https://doi.org/10.4081/reumatismo.2005.4s.30

1144

PDF: 894
COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

173-177

19-11-2020

https://doi.org/10.4081/reumatismo.2020.1289

1634

PDF: 1013
Effects of TNF antagonists on immune and neuroendocrine system

G. Valesini, M. Cutolo

3-7

https://doi.org/10.4081/reumatismo.2005.4s.3

1186

PDF: 777
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

F.M. Perrotta, A. Delle Sedie, S. Scriffignano, P. Volpe, E. Cordisco, N. Milano, M. Gabini, E. Lubrano

52-59

10-04-2020

https://doi.org/10.4081/reumatismo.2020.1266

1975

PDF: 1122
MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

P. Sfriso, F. Salaffi, C.M. Montecucco, S. Bombardieri, S. Todesco

132-139

https://doi.org/10.4081/reumatismo.2009.132

1917

PDF: 1140
The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1470

9367

PDF: 2074
Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

07-02-2022

https://doi.org/10.4081/reumatismo.2021.1453

5710

PDF: 675
Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

07-01-2025

https://doi.org/10.4081/reumatismo.2025.1682

1467

PDF: 113

1 - 15 of 15 items

Search

Search Results

Psoriatic arthritis: treatment strategies using biologic agents

Psoriatic arthritis. When the heterogeneity requires normality

BIOLOGIC THERAPY OF PSORIATIC ARTHRITIS

Treatment of spondyloarthritis with disease-modifying anti-rheumatic drugs during pregnancy and breastfeeding: comparing the recommendations and guidelines of the principal societies of rheumatology

Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases

Treatment of Wegener’s granulomatosis

The risk/benefit profile of biologic drugs in real-world rheumatology practice. From ANTARES to MonitorNet

Approved indications and other possible utilizations of anti-TNFa biologic drugs

COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

Effects of TNF antagonists on immune and neuroendocrine system

Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study

MonitorNet: studio italiano osservazionale multicentrico per la valutazione del profilo rischio-beneficio dei farmaci biologici nella pratica clinica reumatologica

The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

authors

reviewers

Categories

indexing

Keywords